{"id":"NCT01498068","sponsor":"Janssen-Cilag International NV","briefTitle":"Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C","officialTitle":"Open-Label, Bridging Study to Determine Efficacy and Safety of Telaprevir, Pegylated-Interferon-alfa-2a and Ribavirin in Treatment- Naïve and Treatment-Experienced Russian Subjects With Genotype 1 Chronic Hepatitis C","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01","primaryCompletion":"2012-04","completion":"2013-03","firstPosted":"2011-12-23","resultsPosted":"2013-12-30","lastUpdate":"2015-01-30"},"enrollment":36,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Genotype 1 Chronic Hepatitis C"],"interventions":[{"type":"DRUG","name":"Telaprevir","otherNames":[]},{"type":"DRUG","name":"Pegylated-interferon-alfa-2a","otherNames":[]},{"type":"DRUG","name":"Ribavirin","otherNames":[]}],"arms":[{"label":"Treatment-naïve","type":"EXPERIMENTAL"},{"label":"Treatment-experienced","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine the effectiveness, safety and tolerability of telaprevir administered as 750 mg every 8 hours (q8h) in combination with pegylated interferon (Peg-IFN)-alfa-2a and ribavirin (RBV) in treatment-naïve and treatment-experienced Russian participants with genotype 1 chronic hepatitis C.","primaryOutcome":{"measure":"Number of Participants With Extended Rapid Virologic Response (eRVR)","timeFrame":"Week 4 and Week 12","effectByArm":[{"arm":"Treatment-naïve","deltaMin":13,"sd":null},{"arm":"Treatment-experienced","deltaMin":18,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":5,"countries":["Russia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":16},"commonTop":["Influenza like illness","Anaemia","Pyrexia","Asthenia","Neutropenia"]}}